Nippon India Pharma Fund Direct Bonus
Summary Info
Fund Name
: Nippon India Mutual Fund
Scheme Name
: Nippon India Pharma Fund Direct Bonus
AMC
: Nippon India Mutual Fund
Type
: Open
Category
: Equity - Pharma
Launch Date
: 01-Jan-2013
Fund Manager
: Sailesh Raj Bhan
Net Assets (Rs. cr)
: 8569.15
Nippon India Pharma Fund Direct Bonus - Nav Details
Nav Date
: 07-Aug-2025
NAV [Rs.]
: 564.2401
Buy/Resale Price [Rs.]
: 0
Sell/Repurchase Price [Rs.]
: 0
Entry Load %
:
Exit Load %
:
Nippon India Pharma Fund Direct Bonus- NAV Chart
Nippon India Pharma Fund Direct Bonus- Performance(%)
Returns above 1 yr. are annualized
1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | Since INC | |
|---|---|---|---|---|---|---|---|---|
| Scheme Returns | -4.59 | -2.97 | 3.02 | 2.33 | 3.01 | 23.13 | 19.82 | 17.97 |
| Category Avg | -3.72 | -2.03 | 4.45 | 1.15 | 5.74 | 23.34 | 19.29 | 16.24 |
| Category Best | -2.82 | 0.07 | 7.82 | 4.75 | 19.16 | 28.05 | 22.5 | 35.27 |
| Category Worst | -5.44 | -6.8 | 1.38 | -4.05 | -10.12 | 18.75 | 14.45 | -4.23 |
Nippon India Pharma Fund Direct Bonus- Latest Dividends
No Records Found
Nippon India Pharma Fund Direct Bonus- Investment Details
Min. Investment(Rs.)
: 5000
Increm.Investment(Rs.)
: 1000
In & Out
In
InName Of The CompanyNo Of Shares
Anthem Bioscienc10,58,503
Out
InName Of The CompanyNo Of Shares
--
Fund Holdings
Asset Type | Instrument Name | Industry | Net Assets(%) | No of Shares | Mkt Value(Cr.) |
|---|---|---|---|---|---|
| Equity & Equity related Investments | |||||
| Equity | Sun Pharma.Inds. | Pharmaceuticals & Biotechnology | 12.22 | 6256349 | 1,067.77 |
| Equity | Divi's Lab. | Pharmaceuticals & Biotechnology | 7.55 | 1000031 | 659.57 |
| Equity | Lupin | Pharmaceuticals & Biotechnology | 5.93 | 2683991 | 517.76 |
| Equity | Cipla | Pharmaceuticals & Biotechnology | 5.69 | 3200000 | 497.47 |
| Equity | Dr Reddy's Labs | Pharmaceuticals & Biotechnology | 5.69 | 3916074 | 497.45 |
| Equity | Apollo Hospitals | Healthcare Services | 5.57 | 648795 | 486.46 |
| Equity | Medplus Health | Retailing | 3.86 | 3627277 | 337.53 |
| Equity | Vijaya Diagnost. | Healthcare Services | 3.55 | 2886684 | 310.33 |
| Equity | Glaxosmi. Pharma | Pharmaceuticals & Biotechnology | 3.31 | 913226 | 288.81 |
| Equity | Gland Pharma | Pharmaceuticals & Biotechnology | 3.12 | 1320549 | 272.66 |
| Equity | Ajanta Pharma | Pharmaceuticals & Biotechnology | 3.02 | 959323 | 263.94 |
| Equity | Abbott India | Pharmaceuticals & Biotechnology | 2.70 | 68677 | 236.28 |
| Equity | Thyrocare Tech. | Healthcare Services | 2.63 | 1733833 | 229.88 |
| Equity | Dr Lal Pathlabs | Healthcare Services | 2.38 | 659112 | 207.67 |
| Equity | Sai Life | Pharmaceuticals & Biotechnology | 2.36 | 2555745 | 206.61 |
| Equity | Narayana Hrudaya | Healthcare Services | 2.26 | 1029215 | 197.11 |
| Equity | Mankind Pharma | Pharmaceuticals & Biotechnology | 2.23 | 757496 | 194.46 |
| Equity | Aurobindo Pharma | Pharmaceuticals & Biotechnology | 2.22 | 1702630 | 194.06 |
| Equity | Zydus Lifesci. | Pharmaceuticals & Biotechnology | 2.22 | 2000632 | 194.02 |
| Equity | J B Chemicals & | Pharmaceuticals & Biotechnology | 2.02 | 999649 | 176.86 |
| Equity | Pfizer | Pharmaceuticals & Biotechnology | 1.89 | 318249 | 165.31 |
| Equity | Alkem Lab | Pharmaceuticals & Biotechnology | 1.86 | 323678 | 162.84 |
| Equity | Biocon | Pharmaceuticals & Biotechnology | 1.77 | 3953457 | 154.73 |
| Equity | Sanofi India | Pharmaceuticals & Biotechnology | 1.54 | 230272 | 134.13 |
| Equity | Suraksha Diagno. | Healthcare Services | 1.34 | 3896349 | 117.26 |
| Equity | Ipca Labs. | Pharmaceuticals & Biotechnology | 1.33 | 785412 | 115.76 |
| Equity | Torrent Pharma. | Pharmaceuticals & Biotechnology | 1.30 | 303364 | 113.51 |
| Equity | Sanofi Consumer | Pharmaceuticals & Biotechnology | 1.20 | 213659 | 104.86 |
| Equity | Fortis Health. | Healthcare Services | 1.08 | 1103889 | 94.65 |
| Equity | Syngene Intl. | Healthcare Services | 1.05 | 1280492 | 91.42 |
| Equity | Anthem Bioscienc | Pharmaceuticals & Biotechnology | 0.92 | 1058503 | 80.35 |
| Equity | Akums Drugs | Pharmaceuticals & Biotechnology | 0.90 | 1515264 | 78.68 |
| Equity | Emcure Pharma | Pharmaceuticals & Biotechnology | 0.76 | 470272 | 66.28 |
| Equity | Indoco Remedies | Pharmaceuticals & Biotechnology | 0.67 | 1834924 | 58.32 |
| Equity | Astrazeneca Phar | Pharmaceuticals & Biotechnology | 0.66 | 62568 | 57.47 |
| Equity | Orchid Pharma | Pharmaceuticals & Biotechnology | 0.42 | 492727 | 36.48 |
| Equity | Concord Biotech | Pharmaceuticals & Biotechnology | 0.23 | 111738 | 19.74 |
| Cash & Cash Equivalent | |||||
| Net CA & Others | Net CA & Others | -/- | 0.29 | 0 | 24.90 |
| Reverse Repo | TREPS | -/- | 0.26 | 0 | 22.81 |
| Cash & Cash Equivalent | C C I | -/- | 0.00 | 0 | 0.15 |
MY WEALTH AT RETIREMENT
Calculate the worth of your wealth at retirement
Key information
Fund House:
Nippon India Mutual Fund
Incorporation Date:
24-Feb-1995
Total Assets Managed (Cr.):
6,17,875.24
Trustee/s:
Mr. A N Shanbhag - Associ, Nippon Life India Trustee
Chairman:
NA
CEO / MD:
Mr. Sundeep Sikka
CIO:
NA
President:
NA
Director/s:
Mr. Akira Shibata, Mr. Sushil C. Tripathi, Mr. Kazuhide Toda, Mr. Takayuki Murai
Compliance Officer/s:
Mr. Muneesh Sud
Investor Service Officer/s:
Mr. Milind Nesarikar
Fund Manager/s:
Sailesh Raj Bhan
Auditors:
Haribhakti & Co LLP Chart
OTHER INFORMATION
Registered Office:
4th Floor, Tower A, Peninsula Busines -s Park, Ganapatrao Kadam Marg Lower Parel (W), Mumbai - 400013.
Contact Nos:
022-68087000/1860260111
Fax:
022-68087097
Website:
